Filing Flows › Utah Medical Products (UTMD) › Operating margin
Utah Medical Products (UTMD) operating margin by quarter
Utah Medical Products' operating margin was 31.1% in Q2 2026 (second quarter 2026), +1.7 pts from Q1 2026. Over the last 7 quarters it ranged from 26.6% (Q3 2025) to 32.5% (Q1 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 31.1% | +1.7 pts | -1.1 pts |
| Q1 2026 | 29.4% | +2.4 pts | -3.1 pts |
| Q4 2025 | 27.0% | +0.4 pts | -5.0 pts |
| Q3 2025 | 26.6% | -5.5 pts | — |
| Q2 2025 | 32.1% | -0.4 pts | — |
| Q1 2025 | 32.5% | +0.5 pts | — |
| Q4 2024 | 32.0% | — | — |
Q2 2026 at a glance
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Utah Medical Products' operating margin?
Utah Medical Products' operating margin was 31.1% in Q2 2026 (second quarter 2026), +1.7 pts from Q1 2026.
How has Utah Medical Products' operating margin changed?
Over the last 7 quarters it ranged from 26.6% (Q3 2025) to 32.5% (Q1 2025).